Update: foghorn therapeutics to present poster and chair a panel at the aacr annual meeting 2021

Cambridge, mass., march 11, 2021 (globe newswire) -- foghorn therapeutics inc. (nasdaq: fhtx), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that the company will present a poster and chair a panel at the american association for cancer research (aacr) annual meeting 2021, which is being held virtually from april 10-15.
FHTX Ratings Summary
FHTX Quant Ranking